Skip to content
10-Q

Quarterly Report

HARTE HANKS, INC. HHS

0000045919-25-000028

← back to feed
Filed
May 15, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 7.36M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $36.09M
Current Liabilities Q1 2025 · Dec 31, 2024 $35.14M
Total Liabilities Q1 2025 · Mar 31, 2025 $79.16M
Total Liabilities Q1 2025 · Dec 31, 2024 $80.09M
Current Assets Q1 2025 · Mar 31, 2025 $53.72M
Current Assets Q1 2025 · Dec 31, 2024 $53.61M
Total Assets Q1 2025 · Mar 31, 2025 $100.59M
Total Assets Q1 2025 · Dec 31, 2024 $101.78M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $9.93M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $11.46M
Shares Diluted Q1 2025 · Mar 31, 2024 7.24M sh
Capex Q1 2025 · Mar 31, 2024 $526K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$5.69M
Stockholders Equity Q1 2025 · Mar 31, 2024 $19.96M
Stockholders Equity Q1 2025 · Dec 31, 2023 $19.86M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.02
Eps Basic Q1 2025 · Mar 31, 2024 −$0.02
Sga Expense Q1 2025 · Mar 31, 2024 $5.94M
Net Income Q1 2025 · Mar 31, 2024 −$171K
Operating Income Q1 2025 · Mar 31, 2024 $375K
Revenue Q1 2025 · Mar 31, 2024 $45.45M